2.72
1.81%
-0.05
Aclaris Therapeutics Inc (ACRS) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
86.35%
2.398
|
17.57 | 9.282 | 1.869 | 2.528 |
Cost Of Revenue |
11.59%
0.809
|
0.725 | 0.848 | 1.042 | 0.808 |
Gross Profit |
90.57%
1.589
|
16.84 | 8.434 | 0.827 | 1.72 |
Operating Expenses
|
1.78%
20.52
|
20.89 | 40.01 | 32.64 | 31.64 |
Benefits Costs and Expenses |
0.46%
19.34
|
19.43 | 40.86 | 33.68 | 30.69 |
Costs And Expenses |
1.33%
21.33
|
21.62 | 40.86 | 33.68 | 32.45 |
Operating Income/Loss |
367.78%
-18.93
|
-4.047 | -31.58 | -31.82 | -29.92 |
Income/Loss From Continuing Operations Before Tax |
811.79%
-16.94
|
-1.858 | -31.58 | -29.57 | -28.16 |
Income Tax Expense/Benefit |
100.00%
-
|
-0.367 | - | - | - |
Income/Loss From Continuing Operations After Tax |
1,036%
-16.94
|
-1.491 | -29.26 | -29.57 | -28.16 |
Net Income/Loss
|
1,036%
-16.94
|
-1.491 | -29.26 | -29.57 | -28.16 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
19,845%
71.07
|
0.3564 | 70.81 | 70.63 | 66.87 |
Diluted Average Shares |
19,845%
71.07
|
0.3564 | 70.81 | 70.63 | 66.87 |
Basic Earnings Per Share |
1,100%
-0.24
|
-0.02 | -0.41 | -0.42 | -0.42 |
Diluted Earnings Per Share |
1,100%
-0.24
|
-0.02 | -0.41 | -0.42 | -0.42 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):